U.S. top court allows Apotex to pursue generic version of Daiichi drug

WASHINGTON (Reuters) - The U.S. Supreme Court on Monday rejected appeals by Daiichi Sankyo Inc and Mylan Pharmaceuticals Inc seeking to stop Apotex Inc from trying to introduce a generic version of Benicar, a drug for treating hypertension.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news